Literature DB >> 25448287

17-β estradiol attenuates ovariectomy-induced changes in cardiomyocyte contractile function via activation of AMP-activated protein kinase.

Subat Turdi1, Anna F Huff1, Jiaojiao Pang2, Emily Y He1, Xiyao Chen3, Shuyi Wang1, Yuguo Chen4, Yingmei Zhang5, Jun Ren6.   

Abstract

Menopause increases the risk of cardiometabolic diseases in women. This circumstance is usually attributed to a deficiency in circulating estrogen levels although the underlying mechanism remains elusive. Given the pivotal role of AMP-activated protein kinase (AMPK) in the regulation of energy metabolism and cardiac function, this study was designed to examine the role of AMPK in estrogen deficiency and replacement-exerted cardiomyocyte responses. Adult female WT and AMPK kinase dead (KD) mice were subjected to bilateral ovariectomy (OVX) or sham operation. A cohort of ovariectomized mice received 17β-estradiol (E2) (40μg/kg/day, i.p.) for 6 weeks. Mechanical and intracellular Ca(2+) properties were evaluated including peak shortening (PS), time-to-PS (TPS), time-to-90%-relengthening (TR90), and maximal velocity of shortening/relengthening (±dL/dt). Levels of AMPK, Akt JNK, ACC, SERCA, membrane Glut4, AS160 and PGC-1α were assessed using Western blot. OVX significantly decreased PS, ±dL/dt and intracellular Ca(2+) rise in responsible to electric stimulus, prolonged TR90 and intracellular Ca(2+) decay without affecting TPS and resting intracellular Ca(2+), the effects of which were reconciled by E2 replacement. Western blot analysis depicted that OVX suppressed phosphorylation of Akt AMPK and ACC although it promoted JNK phosphorylation, the effects of which were mitigated or significantly attenuated by E2 treatment in WT but not KD mice. Moreover, OVX procedure downregulated SERCA2a and membrane Glut4 while inhibiting AS160 phosphorylation without affecting PGC-1α levels. In vitro study revealed that E2 corrected cardiomyocyte contractile dysfunction elicited by OVX in cardiomyocytes from WT but not the AMPK kinase dead mice. Taken together, these data suggest that E2 treatment ameliorates estrogen deficiency-induced changes in cardiac contractile function possibly through an AMPK-dependent mechanism.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AMPK; Cardiomyocyte; Contractile Function; Estrogen; Estrogen replacement

Mesh:

Substances:

Year:  2014        PMID: 25448287      PMCID: PMC4430453          DOI: 10.1016/j.toxlet.2014.11.012

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  46 in total

Review 1.  Oestrogen's regulation of fat metabolism during exercise and gender specific effects.

Authors:  Tanja Oosthuyse; Andrew N Bosch
Journal:  Curr Opin Pharmacol       Date:  2012-03-05       Impact factor: 5.547

2.  Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β.

Authors:  Han Liu; Ali Pedram; Jin Kyung Kim
Journal:  Cardiovasc Res       Date:  2010-08-19       Impact factor: 10.787

3.  AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction.

Authors:  Subat Turdi; Xiujuan Fan; Ji Li; Junxing Zhao; Anna F Huff; Min Du; Jun Ren
Journal:  Aging Cell       Date:  2010-05-10       Impact factor: 9.304

Review 4.  Estrogen signaling and cardiovascular disease.

Authors:  Elizabeth Murphy
Journal:  Circ Res       Date:  2011-09-02       Impact factor: 17.367

5.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors:  Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

6.  Influence of ovariectomy on ventricular myocyte contraction in simulated diabetes.

Authors:  K K Hintz; L E Wold; P B Colligan; G I Scott; K J Lee; J R Sowers; J Ren
Journal:  J Biomed Sci       Date:  2001 Jul-Aug       Impact factor: 8.410

Review 7.  Targeting AMPK for cardiac protection: opportunities and challenges.

Authors:  Maengjo Kim; Rong Tian
Journal:  J Mol Cell Cardiol       Date:  2010-12-13       Impact factor: 5.000

Review 8.  AMPK in cardiovascular health and disease.

Authors:  Najeeb A Shirwany; Ming-Hui Zou
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

9.  Structure of mammalian AMPK and its regulation by ADP.

Authors:  Bing Xiao; Matthew J Sanders; Elizabeth Underwood; Richard Heath; Faith V Mayer; David Carmena; Chun Jing; Philip A Walker; John F Eccleston; Lesley F Haire; Peter Saiu; Steven A Howell; Rein Aasland; Stephen R Martin; David Carling; Steven J Gamblin
Journal:  Nature       Date:  2011-03-13       Impact factor: 49.962

Review 10.  AMP-activated protein kinase as a key molecular link between metabolism and clockwork.

Authors:  Yongjin Lee; Eun-Kyoung Kim
Journal:  Exp Mol Med       Date:  2013-07-26       Impact factor: 8.718

View more
  10 in total

1.  Effect of ovariectomy on intracellular Ca2+ regulation in guinea pig cardiomyocytes.

Authors:  Hsiang-Yu Yang; Jahn M Firth; Alice J Francis; Anita Alvarez-Laviada; Kenneth T MacLeod
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-04       Impact factor: 4.733

2.  SIRT1-dependent AMPK pathway in the protection of estrogen against ischemic brain injury.

Authors:  Jin-Min Guo; He Shu; Lei Wang; Jian-Jiang Xu; Xue-Cai Niu; Li Zhang
Journal:  CNS Neurosci Ther       Date:  2017-03-02       Impact factor: 5.243

3.  Estrogen Deficiency Aggravates Fluoride-Induced Liver Damage and Lipid Metabolism Disorder in Rats.

Authors:  Ya-Ming Yu; Bian-Hua Zhou; Yi-Lin Yang; Cheng-Xiang Guo; Jing Zhao; Hong-Wei Wang
Journal:  Biol Trace Elem Res       Date:  2021-08-15       Impact factor: 3.738

4.  Effects of Moderate-Intensity Physical Training on Skeletal Muscle Substrate Transporters and Metabolic Parameters of Ovariectomized Rats.

Authors:  Taciane Maria Melges Pejon; Pedro Paulo Menezes Scariot; Heloísa Sobreiro Selistre-de-Araujo; Claudio Alexandre Gobatto; Anabelle Silva Cornachione; Wladimir Rafael Beck
Journal:  Metabolites       Date:  2022-04-29

Review 5.  Sex Differences in Cardiovascular Aging and Heart Failure.

Authors:  Andrew Oneglia; Michael D Nelson; C Noel Bairey Merz
Journal:  Curr Heart Fail Rep       Date:  2020-09-28

6.  Sex differences in right ventricular adaptation to pressure overload in a rat model.

Authors:  Tik-Chee Cheng; Diana M Tabima; Laura R Caggiano; Andrea L Frump; Timothy A Hacker; Jens C Eickhoff; Tim Lahm; Naomi C Chesler
Journal:  J Appl Physiol (1985)       Date:  2022-02-03

7.  Pomegranate Extract Enhances Endothelium-Dependent Coronary Relaxation in Isolated Perfused Hearts from Spontaneously Hypertensive Ovariectomized Rats.

Authors:  Nathalie T B Delgado; Wender do N Rouver; Leandro C Freitas-Lima; Tiago D-C de Paula; Andressa Duarte; Josiane F Silva; Virgínia S Lemos; Alexandre M C Santos; Helder Mauad; Roger L Santos; Margareth R Moysés
Journal:  Front Pharmacol       Date:  2017-01-04       Impact factor: 5.810

8.  The protective effect of Er-Xian decoction against myocardial injury in menopausal rat model.

Authors:  Zhiguo Zhang; Lihua Xiang; Lanping Zhao; Hong Jiao; Zhen Wang; Yubo Li; Yanjing Chen
Journal:  BMC Complement Altern Med       Date:  2018-09-03       Impact factor: 3.659

Review 9.  Molecular pathways of oestrogen receptors and β-adrenergic receptors in cardiac cells: Recognition of their similarities, interactions and therapeutic value.

Authors:  J O Machuki; H Y Zhang; S E Harding; H Sun
Journal:  Acta Physiol (Oxf)       Date:  2017-10-30       Impact factor: 6.311

Review 10.  The Role of Estrogens and Vitamin D in Cardiomyocyte Protection: A Female Perspective.

Authors:  Clara Crescioli
Journal:  Biomolecules       Date:  2021-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.